TR200200593T2 - Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod. - Google Patents

Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod.

Info

Publication number
TR200200593T2
TR200200593T2 TR2002/00593T TR200200593T TR200200593T2 TR 200200593 T2 TR200200593 T2 TR 200200593T2 TR 2002/00593 T TR2002/00593 T TR 2002/00593T TR 200200593 T TR200200593 T TR 200200593T TR 200200593 T2 TR200200593 T2 TR 200200593T2
Authority
TR
Turkey
Prior art keywords
separation
molecular weight
high molecular
mixture
adsorption
Prior art date
Application number
TR2002/00593T
Other languages
English (en)
Inventor
Higaki Tomoji
Yoshiyasu Takashi
Hasimoto Norihiro
Honda Keiji
Hatanaka Hiroshi
Yamashita Michio
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of TR200200593T2 publication Critical patent/TR200200593T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Lakton içeren, yüksek molekül agirlikli bir bilesigin separasyonuna yönelik bir metod olup, yan zincir olarak sayica düsük karbonlu bir alkenil grubu ve sayica düsük karbonlu bir alkoksi grubundan en az birisini ihtiva eden, lakton içeren yüksek molekül agirlikli bir bilesigin ve bunun analog bilesiginin/bilesiklerinin bir karisiminin bilesiklerin her birisinin separasyonu için asagida belirtilen etaplarin her hangi bir sirasi ile, ya bir etaba, yahut da iki etaba tabi tutulmasini içerir: karisimin non-iyonik bir adsorpsiyon reçinesine adsorpsiyonuna ve gümüs iyonlari içeren sulu bir solvenle elüsyona yönelik bir (A) etabi, ve karisiminin non-iyonik bir temelde aktif aluminaya adsorpsiyonuna ve organik bir solvenle elüsyona yönelik bir (B) etabi.
TR2002/00593T 1999-09-08 2000-09-05 Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod. TR200200593T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25381399 1999-09-08

Publications (1)

Publication Number Publication Date
TR200200593T2 true TR200200593T2 (tr) 2002-07-22

Family

ID=17256507

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00593T TR200200593T2 (tr) 1999-09-08 2000-09-05 Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod.

Country Status (24)

Country Link
US (2) US6576135B1 (tr)
EP (1) EP1210351B1 (tr)
JP (1) JP3925198B2 (tr)
CN (1) CN1195760C (tr)
AR (1) AR025598A1 (tr)
AT (1) ATE263773T1 (tr)
AU (1) AU779331B2 (tr)
BR (1) BR0014016B1 (tr)
CA (1) CA2384440C (tr)
CZ (1) CZ302625B6 (tr)
DE (1) DE60009723T2 (tr)
DK (1) DK1210351T3 (tr)
ES (1) ES2214307T3 (tr)
HK (1) HK1048991A1 (tr)
HU (1) HU230126B1 (tr)
MX (1) MXPA02002370A (tr)
NO (1) NO328422B1 (tr)
NZ (1) NZ517473A (tr)
PL (1) PL195650B1 (tr)
PT (1) PT1210351E (tr)
RU (1) RU2245338C2 (tr)
TR (1) TR200200593T2 (tr)
TW (1) TW553946B (tr)
WO (1) WO2001018007A2 (tr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
EP1474404A4 (en) 2002-02-13 2006-01-11 Biogal Gyogyszergyar PROCESS FOR EXTRACTION OF A BIOLOGICAL MATERIAL
CA2533548C (en) * 2003-07-24 2010-02-16 Teva Gyogyszergyar Reszvenytarsasag Method of purifying macrolides
CA2548297C (en) * 2003-12-05 2011-06-14 Biocon Limited Process for the purification of macrolides
CA2562805C (en) * 2004-04-12 2014-03-11 Biocon Limited Process for the production of macrolides using a novel strain, streptomyces sp. bicc 7522
CA2580127A1 (en) * 2004-09-10 2006-03-23 Ivax Pharmaceuticals S.R.O. Process for isolation of crystalline tacrolimus
ITMI20042098A1 (it) * 2004-11-03 2005-02-03 Antibioticos Spa Processo per la purificazione di tacrolimus
JP2007519758A (ja) * 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 結晶マクロライドの生成方法
WO2006069333A1 (en) * 2004-12-22 2006-06-29 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Method of purifying macrolides
WO2006083486A1 (en) * 2005-01-05 2006-08-10 TEVA GYÓGYSZERGYÁR ZÁRTKöR..EN M..k..D.. RÉSZVÉNYTÁRSASÁG Amorphous tacrolimus and preparation thereof
WO2007013017A1 (en) * 2005-07-29 2007-02-01 Ranbaxy Laboratories Limited A process for purification of macrolides
ITMI20051549A1 (it) * 2005-08-05 2007-02-06 Antibioticos Spa Purificazione del tacrolimus su supporti dimorigine vegetale
JP4700022B2 (ja) * 2006-03-15 2011-06-15 アイバックス ファーマシューティカルズ スポレツノスト エス ルチェニム オメゼニム タクロリマスの精製方法
WO2007106587A2 (en) * 2006-03-15 2007-09-20 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Process for purifying tacrolimus
JP5602626B2 (ja) * 2007-06-29 2014-10-08 アーティフィシャル マッスル，インク． 感覚性フィードバック用途のための電気活性ポリマートランスデューサー
KR101022067B1 (ko) 2008-05-30 2011-03-17 이연제약주식회사 고순도 타크로리무스의 회수방법
KR100910165B1 (ko) 2008-09-18 2009-07-30 (주) 제노텍 은 이온 용액 추출을 이용한 불포화 알킬기를 가진 락톤 화합물 정제방법
US20110318277A1 (en) 2010-06-25 2011-12-29 APT Pharmaceuticals, Inc. University of Maryland, Baltimore Tacrolimus compositions for aerosol administration
JP6210983B2 (ja) 2012-07-06 2017-10-11 合同酒精株式会社 環状マクロライド系化合物の分離方法
RU2694354C1 (ru) * 2018-09-25 2019-07-11 Закрытое акционерное общество "БиоХимМак СТ" Способ сорбционно-хроматографического выделения и очистки такролимуса

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8406218D0 (en) 1984-03-09 1984-04-11 Glaxo Group Ltd Process
AU600187B2 (en) * 1987-12-15 1990-08-02 Unilever Plc Process for concentrating lactones, as well as the use of the concentrate thus obtained for flavouring foodstuffs
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
JPH03191788A (ja) 1989-12-19 1991-08-21 Nippon Kayaku Co Ltd 新規抗生物質ｎｋ１５５１４１およびその製造法
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds

Also Published As

Publication number Publication date
CN1373764A (zh) 2002-10-09
NO20021024L (no) 2002-05-02
NO20021024D0 (no) 2002-03-01
AU779331B2 (en) 2005-01-20
CZ302625B6 (cs) 2011-08-10
CZ2002860A3 (cs) 2002-08-14
US6881341B2 (en) 2005-04-19
TW553946B (en) 2003-09-21
JP3925198B2 (ja) 2007-06-06
BR0014016A (pt) 2002-05-21
HUP0203196A2 (hu) 2002-12-28
US20030168409A1 (en) 2003-09-11
DE60009723D1 (de) 2004-05-13
DE60009723T2 (de) 2005-04-28
EP1210351B1 (en) 2004-04-07
HUP0203196A3 (en) 2003-12-29
PL195650B1 (pl) 2007-10-31
AU6871300A (en) 2001-04-10
AR025598A1 (es) 2002-12-04
PT1210351E (pt) 2004-08-31
ES2214307T3 (es) 2004-09-16
CN1195760C (zh) 2005-04-06
RU2245338C2 (ru) 2005-01-27
MXPA02002370A (es) 2002-08-20
EP1210351A2 (en) 2002-06-05
HK1048991A1 (en) 2003-04-25
CA2384440A1 (en) 2001-03-15
HU230126B1 (hu) 2015-08-28
WO2001018007A2 (en) 2001-03-15
BR0014016B1 (pt) 2011-07-12
US6576135B1 (en) 2003-06-10
CA2384440C (en) 2009-02-17
WO2001018007A3 (en) 2001-07-26
NO328422B1 (no) 2010-02-15
ATE263773T1 (de) 2004-04-15
JP2003508536A (ja) 2003-03-04
PL353802A1 (en) 2003-12-01
NZ517473A (en) 2004-01-30
DK1210351T3 (da) 2004-08-02

Similar Documents

Publication Publication Date Title
TR200200593T2 (tr) Lakton içeren, yüksek molekül ağırlıklı bileşiklerin seperasyonuna yönelik metod.
TR199801587A2 (tr) Insülin öncü moleküllerinin elde edilmesine yönelik yöntem.
BRPI0516463A (pt) cánula escalonada e conjunto de cánula
BR0112693B1 (pt) (derivados) de Ácido sulfonilaminometilbenzàico substituÍdos, bem como processo para preparaÇço e uso dos mesmos.
BR9701462B1 (pt) hidroxifeniltriazinas, composiÇÕes, processo para estabilizar polÍmeros ou prÉ-polÍmeros orgÂnicos sintÉticos contra dano causado por luz, oxigÊnio e/ou calor, bem como uso dos referidos compostos.
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
BR9807502B1 (pt) compostos orgÂnicos, processo para sua preparaÇço, bem como composiÇço e aplicaÇço dos mesmos.
ES2105698T3 (es) Oligonucleotidos modificados con 7-deazapurina.
MXPA03004680A (es) Materiales antimicrobianos estabilizados con respecto a la luz.
BRPI9809791B8 (pt) compostos imuno efetores de fosfato de aminoalquil glucosamina e composições compreendendo os mesmos
TR200001892T2 (tr) Monomer cinsi ensülin analogları ve bunların kullanımı.
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
TR200103360T2 (tr) Benzer organik bileşikleri ayırma yöntemi.
ATE309805T1 (de) Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach- medikamentresistenz in krebs- und anderen zellen
WO2001089571A3 (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
FI964285A0 (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
WO2001064834A8 (en) Novel nucleic acids and polypeptides
ES2150275T3 (es) Utilizacion de un extracto de algas como agente antibacteriano y/o antifungico, y compuesto que comprende dicho extracto.
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona
ATE214803T1 (de) Stabilisierte standards und kalibratoren
DE59912715D1 (de) Antimikrobielle zusammensetzung
BR9402818A (pt) Composto, composição, processo para estabilização de um material orgânico e uso
DE68917453D1 (de) Adamantan-Derivate, Verfahren zu deren Herstellung, diese enthaltende Mittel sowie deren Verwendung als Organoleptika und Deodorantien.
ATE250130T1 (de) Gereinigte telomerase
ATE103485T1 (de) Haarbehandlungsmittel.